Stay updated on Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Publications section description updated to clarify automatic PubMed population; page revision label updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-24T17:46:16.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page no longer displays the government funding/operating status notice; core study details and eligibility sections appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T17:29:08.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The page shows only minor updates such as timestamp changes and small wording edits, with no changes to core content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T11:48:20.000Z thumbnail image
  5. Check
    64 days ago
    Change Detected
    Summary
    Updated operating-status notice and added Bone osteosarcoma topic; removed old revision tag and added new revision tag v3.2.0.
    Difference
    2%
    Check dated 2025-10-05T16:42:21.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.
    Difference
    0.0%
    Check dated 2025-09-28T10:07:35.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    Page now shows Revision: v3.0.2, replacing v3.0.1. The 'Back to Top' link has been removed.
    Difference
    0.1%
    Check dated 2025-09-14T00:14:53.000Z thumbnail image

Stay in the know with updates to Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial page.